EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial

Hiroyuki Ohbayashi iD, Mitsue Ariga, Kunihiro Ohta, Sahori Kudo, Osamu Furuta, Akinori Yamamoto

International Journal of Chronic Obstructive Pulmonary Disease · 2024

DOI: 10.2147/copd.s441767 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Hiroyuki Ohbayashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Corporation, Syureikai, Tohno Chuo Clinic, Mizunami City, Gifu, Japan. Hauptthemen laut MEDLINE: Sarcopenia, Pulmonary Disease, Chronic Obstructive, Drugs, Chinese Herbal, Muscle Strength. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To present the preliminarily findings regarding the effects of a herbal medicine, Ninjin'yoeito, on comorbid frailty and sarcopenia in patients with chronic obstructive pulmonary disease (COPD). Patients and Methods: Patients with COPD (GOLD II or higher) and fatigue were randomly assigned to Group A (n = 28; no medication for 12 weeks, followed by 12-week administration) or B (n= 25; 24-week continuous administration). Visual analog scale (VAS) symptoms of fatigue, the COPD assessment test (CAT), and the modified Medical Research Council (mMRC) Dyspnea Scale were examined. Physical indices such asknee extension leg strength and walking speed, skeletal muscle mass index (SMI), and respiratory function test were also measured.

Results

VAS fatigue scales in Group B significantly improved after 4, 8, and 12 weeks compared to those in Group A (each p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaPulmonary Disease, Chronic ObstructiveDrugs, Chinese HerbalMuscle StrengthLungExercise ToleranceFrailtyHumansMaleFemaleAgedTreatment OutcomeMiddle AgedTime FactorsComorbidityFatigueRecovery of FunctionFunctional StatusFrail ElderlyWalking Speed

Stichwörter der Autor:innen

Ninjin’yoeitoclinical studyfrailtysarcopeniatherapeutic effect

Substanzen

Drugs, Chinese Herbalninjin'yoeito

Autor:innen und Institutionen

  • Medical Corporation, Syureikai, Tohno Chuo Clinic, Mizunami City, Gifu, Japan.

ORCID-Profile: Hiroyuki Ohbayashi

Zitieren

APA

Ohbayashi, H., Ariga, M., Ohta, K., Kudo, S., Furuta, O., & Yamamoto, A. (2024). Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s441767

Vancouver

Ohbayashi H, Ariga M, Ohta K, Kudo S, Furuta O, Yamamoto A. Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s441767

BibTeX
@article{Ohbayashi2024,
  author = {Ohbayashi, Hiroyuki and Ariga, Mitsue and Ohta, Kunihiro and Kudo, Sahori and Furuta, Osamu and Yamamoto, Akinori},
  title = {Effects of Ninjin’yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  doi = {10.2147/copd.s441767}
}
Kostenlos starten →